Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain

The mechanisms underlying selective serotonin reuptake inhibitor (SSRI) use during pregnancy as a major autism risk factor are unclear. Here, brain neurochemical changes following fluoxetine exposure and in an autism model were compared to determine the effects on autism risk. The study was performe...

Full description

Bibliographic Details
Main Authors: Ramesa Shafi Bhat, Mona Alonazi, Sooad Al-Daihan, Afaf El-Ansary
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/2/310
_version_ 1797619291775827968
author Ramesa Shafi Bhat
Mona Alonazi
Sooad Al-Daihan
Afaf El-Ansary
author_facet Ramesa Shafi Bhat
Mona Alonazi
Sooad Al-Daihan
Afaf El-Ansary
author_sort Ramesa Shafi Bhat
collection DOAJ
description The mechanisms underlying selective serotonin reuptake inhibitor (SSRI) use during pregnancy as a major autism risk factor are unclear. Here, brain neurochemical changes following fluoxetine exposure and in an autism model were compared to determine the effects on autism risk. The study was performed on neonatal male western albino rats which were divided into Groups one (control), two (propionic acid [PPA]-induced autism model), and three (prenatal SSRI-exposed newborn rats whose mothers were exposed to 5 mg/kg of fluoxetine over gestation days 10–20). SSRI (fluoxetine) induced significant neurochemical abnormalities in the rat brain by increasing lipid peroxide (MDA), Interferon-gamma (IFN-γ), and caspase-3 levels and by depleting Glutathione (GSH), Glutathione S-transferases (GST), Catalase, potassium (K+), and Creatine kinase (CK) levels, similarly to what has been discovered in the PPA model of autism when compared with control. Prenatal fluoxetine exposure plays a significant role in asset brain damage in newborns; further investigation of fluoxetine as an autism risk factor is thus warranted.
first_indexed 2024-03-11T08:26:01Z
format Article
id doaj.art-33c794e6e0874cd892994395f9a4f37a
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-11T08:26:01Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-33c794e6e0874cd892994395f9a4f37a2023-11-16T22:05:47ZengMDPI AGMetabolites2218-19892023-02-0113231010.3390/metabo13020310Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the BrainRamesa Shafi Bhat0Mona Alonazi1Sooad Al-Daihan2Afaf El-Ansary3Biochemistry Department, College of Science, King Saud University, Riyadh 11495, Saudi ArabiaBiochemistry Department, College of Science, King Saud University, Riyadh 11495, Saudi ArabiaBiochemistry Department, College of Science, King Saud University, Riyadh 11495, Saudi ArabiaCentral Research Laboratory, Female Campus, King Saud University, Riyadh 11495, Saudi ArabiaThe mechanisms underlying selective serotonin reuptake inhibitor (SSRI) use during pregnancy as a major autism risk factor are unclear. Here, brain neurochemical changes following fluoxetine exposure and in an autism model were compared to determine the effects on autism risk. The study was performed on neonatal male western albino rats which were divided into Groups one (control), two (propionic acid [PPA]-induced autism model), and three (prenatal SSRI-exposed newborn rats whose mothers were exposed to 5 mg/kg of fluoxetine over gestation days 10–20). SSRI (fluoxetine) induced significant neurochemical abnormalities in the rat brain by increasing lipid peroxide (MDA), Interferon-gamma (IFN-γ), and caspase-3 levels and by depleting Glutathione (GSH), Glutathione S-transferases (GST), Catalase, potassium (K+), and Creatine kinase (CK) levels, similarly to what has been discovered in the PPA model of autism when compared with control. Prenatal fluoxetine exposure plays a significant role in asset brain damage in newborns; further investigation of fluoxetine as an autism risk factor is thus warranted.https://www.mdpi.com/2218-1989/13/2/310SSRIautismoxidative stressneurotransmittersfluoxetine
spellingShingle Ramesa Shafi Bhat
Mona Alonazi
Sooad Al-Daihan
Afaf El-Ansary
Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
Metabolites
SSRI
autism
oxidative stress
neurotransmitters
fluoxetine
title Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
title_full Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
title_fullStr Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
title_full_unstemmed Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
title_short Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
title_sort prenatal ssri exposure increases the risk of autism in rodents via aggravated oxidative stress and neurochemical changes in the brain
topic SSRI
autism
oxidative stress
neurotransmitters
fluoxetine
url https://www.mdpi.com/2218-1989/13/2/310
work_keys_str_mv AT ramesashafibhat prenatalssriexposureincreasestheriskofautisminrodentsviaaggravatedoxidativestressandneurochemicalchangesinthebrain
AT monaalonazi prenatalssriexposureincreasestheriskofautisminrodentsviaaggravatedoxidativestressandneurochemicalchangesinthebrain
AT sooadaldaihan prenatalssriexposureincreasestheriskofautisminrodentsviaaggravatedoxidativestressandneurochemicalchangesinthebrain
AT afafelansary prenatalssriexposureincreasestheriskofautisminrodentsviaaggravatedoxidativestressandneurochemicalchangesinthebrain